Doni Bloomfield | The Seattle Times

March 28, 2016 at 9:19 am

Alder shares surge on test results for migraine treatment

The Bothell-based biotech’s stock rose as much as 62 percent, its biggest intraday gain ever, after saying that its experimental infusion to prevent migraines met...

December 21, 2015 at 7:42 am

Shkreli fired as CEO of KaloBios after arrest

Martin Shkreli was fired as chief executive officer of KaloBios Pharmaceuticals Inc. following his arrest last week on charges of securities fraud.

Business

Seattle, Wa. January 14, 2015
Juno Therapeutics, a cancer Immunotherapy research lab, brought in the most venture capital this year.
Nate Chartrand, at right, and Nathan Yee prepare cell samples for the laser based flow cytometer to analyze.

June 29, 2015 at 2:36 pm

Juno shares jump as Celgene pays $1 billion for stake

Celgene will pay Seattle-based Juno Therapeutics about $1 billion as part of a 10-year partnership to study cures for cancer and autoimmune diseases.

November 15, 2014 at 8:00 pm

High-speed ad traders profit from arbitraging your eyeballs

The high-frequency trading pioneered on Wall Street has come to Madison Avenue. Arbitrageurs are buying millions of online ads and reselling them for a profit...

Business

November 10, 2014 at 2:07 pm

CNN stops broadcasting in Russia as Putin tightens media reins

CNN, the cable news channel owned by Time Warner, will stop broadcasting in Russia after a new law was passed that limits foreign ownership in...

Nation & World

September 24, 2014 at 11:25 pm

BlackBerry CEO takes jab at Apple: Try bending our phone

BlackBerry couldn’t resist taking a jab at the world’s most popular phone. Over the past seven years, Apple’s iPhone has wrested the smartphone market from...

Business